RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse
Authors:
- Jaebeom ChoJCJaebeom Cho
- Hye-Young MinHMHye-Young Min
- Ho Jin LeeHLHo Jin Lee
- Seung Yeob HyunSHSeung Yeob Hyun
- Jeong Yeon SimJSJeong Yeon Sim
- Myungkyung NohMNMyungkyung Noh
- Su Jung HwangSHSu Jung Hwang
- Shin-Hyung ParkSPShin-Hyung Park
- Hye-Jin BooHBHye-Jin Boo
- Hyo-Jong LeeHyo-Jong Lee
- Sungyoul HongSHSungyoul Hong
- Rang-Woon ParkRPRang-Woon Park
- 4 January 2021
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 131 (1)
Abstract
Slow-cycling/dormant cancer cells (SCCs) have pivotal roles in driving cancer relapse and drug resistance. A mechanistic explanation for cancer cell dormancy and therapeutic strategies targeting SCCs are necessary to improve patient prognosis, but are limited because of technical challenges to obtaining SCCs. Here, by applying proliferation-sensitive dyes and chemotherapeutics to non–small cell lung cancer (NSCLC) cell lines and patient-derived xenografts, we identified a distinct SCC subpopulation that resembled SCCs in patient tumors. These SCCs displayed major dormancy-like phenotypes and high survival capacity under hostile microenvironments through transcriptional upregulation of regulator of G protein signaling 2 (RGS2). Database analysis revealed RGS2 as a biomarker of retarded proliferation and poor prognosis in NSCLC. We showed that RGS2 caused prolonged translational arrest in SCCs through persistent eukaryotic initiation factor 2 (eIF2α) phosphorylation via proteasome-mediated degradation of activating transcription factor 4 (ATF4). Translational activation through RGS2 antagonism or the use of phosphodiesterase 5 inhibitors, including sildenafil (Viagra), promoted ER stress–induced apoptosis in SCCs in vitro and in vivo under stressed conditions, such as those induced by chemotherapy. Our results suggest that a low-dose chemotherapy and translation-instigating pharmacological intervention in combination is an effective strategy to prevent tumor progression in NSCLC patients after rigorous chemotherapy.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2016R1A3B1908631)
This publication has 68 references indexed in Scilit:
- ER-stress-induced transcriptional regulation increases protein synthesis leading to cell deathNature Cell Biology, 2013
- Clinical opportunities and challenges in targeting tumour dormancyNature Reviews Clinical Oncology, 2012
- Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stressNature Cell Biology, 2011
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor GrowthCell, 2010
- Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinomaClinical & Experimental Metastasis, 2009
- Models, mechanisms and clinical evidence for cancer dormancyNature Reviews Cancer, 2007
- Cellular stress increases RGS2 mRNA and decreases RGS4 mRNA levels in SH-SY5Y cellsNeuroscience Letters, 2006
- Coping with stress: eIF2 kinases and translational controlBiochemical Society Transactions, 2006
- ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growthThe EMBO Journal, 2005
- Ovarian cancer: strategies for overcoming resistance to chemotherapyNature Reviews Cancer, 2003